The cholesterol content of erythrocyte membranes as a factor of instability in coronary artery disease patients

被引：0
|
作者：
Tziakas, D
Chalikias, G
Romero, C
Fredericks, S
Theodosis-Georgilas, A
Masci, P
Holt, D
Hatseras, D
Kaski, JC
机构：
[1] Democritus Univ Thrace, Univ Cardiol Clin, Alexandroupolis, Greece
[2] Gen Hosp St Georg, Sch Med, Analyt Unit, London, England
[3] Gen Hosp St Georg, Sch Med, Dept Cardiol Sci, London, England
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2005年 / 6卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(05)80019-4
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：5 / 5
页数：1
相关论文
共 50 条
  • [41] Risk factor profile of coronary artery disease in patient with low cholesterol level
    Lee, YS
    Chang, HJ
    Kim, SH
    Chung, YR
    Hong, DH
    Na, HW
    Jacobson, J
    Choi, SY
    Song, JE
    Choi, B
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 309A - 310A
  • [42] Cholesterol Metabolism in Patients With Hemodialysis in the Presence or Absence of Coronary Artery Disease
    Fukushima, Mikio
    Miura, Shin-ichiro
    Mitsutake, Ryoko
    Fukushima, Takao
    Fukushima, Katsuhiko
    Saku, Keijiro
    CIRCULATION JOURNAL, 2012, 76 (08) : 1980 - 1986
  • [43] Metabolic signatures of cholesterol biosynthesis and absorption in patients with coronary artery disease
    Kwon, Go Eun
    Hyun, Myung Han
    Byun, Dong Jun
    Paeng, Ki-Jung
    Seo, Hong Seog
    Choi, Man Ho
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2021, 212
  • [44] Comparison of the effects of rosuvastatin monotherapy and atorvastatin-ezetimibe combined therapy on the structure of erythrocyte membranes in patients with coronary artery disease
    Małgorzata Olszewska-Banaszczyk
    Paulina Jackowska
    Paulina Gorzelak-Pabiś
    Edyta Pytel
    Maria Koter-Michalak
    Marlena Broncel
    Pharmacological Reports, 2018, 70 : 258 - 262
  • [45] Comparison of the effects of rosuvastatin monotherapy and atorvastatin-ezetimibe combined therapy on the structure of erythrocyte membranes in patients with coronary artery disease
    Olszewska-Banaszczyk, Malgorzata
    Jackowska, Paulina
    Gorzelak-Pabis, Paulina
    Pytel, Edyta
    Koter-Michalak, Maria
    Broncel, Marlena
    PHARMACOLOGICAL REPORTS, 2018, 70 (02) : 258 - 262
  • [46] Factor XIa and tissue factor activity in patients with coronary artery disease
    Butenas, Saulius
    Undas, Anetta
    Gissell, Matthew T.
    Szuldrzynski, Konstanty
    Zmudka, Krzysztof
    Mann, Kenneth G.
    THROMBOSIS AND HAEMOSTASIS, 2008, 99 (01) : 142 - 149
  • [47] FIBRINOGEN, ERYTHROCYTE AGGREGATION AND BLOOD VISCOSITY IN PATIENTS WITH CORONARY-ARTERY DISEASE
    HAHN, R
    MULLERSEYDLITZ, PM
    JOCKEL, KH
    HUBERT, H
    HEIMBURG, P
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 600 - 600
  • [48] Quantity rather type of circulating erythrocyte membrane cholesterol is associated with clinical presentation in coronary artery disease
    Tziakas, D. N.
    Chalikias, G.
    Tentes, I.
    Chatzikyriakou, S.
    Mitrousi, K.
    Kortsaris, A.
    Boudoulas, H.
    Kaski, J. C.
    EUROPEAN HEART JOURNAL, 2008, 29 : 585 - 585
  • [49] CHOLESTEROL CONTENT OF THE CORONARY ARTERIES AND BLOOD IN ACUTE CORONARY ARTERY THROMBOSIS
    MORRISON, LM
    JOHNSON, KD
    AMERICAN HEART JOURNAL, 1950, 39 (01) : 31 - 34
  • [50] EXPERIMENTAL AND CLINICAL STUDY OF THE EFFECT OF BETA SITOSTEROL ADMINISTRATION ON INTESTINAL ABSORPTION OF DIETARY CHOLESTEROL AND THE PLASMA CHOLESTEROL CONTENT OF PATIENTS WITH CORONARY ARTERY DISEASE
    FRIEDMAN, M
    HOMER, R
    BYERS, SO
    CIRCULATION, 1955, 12 (04) : 709 - 709
12345